Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438)

被引:55
作者
Leger, Serge [1 ]
Black, W. Cameron [1 ]
Deschenes, Denis [1 ]
Dolman, Sarah [1 ]
Falgueyret, Jean-Pierre [1 ]
Gagnon, Marc [1 ]
Guiral, Sebastien [1 ]
Huang, Zheng [1 ]
Guay, Jocelyne [1 ]
Leblanc, Yves [1 ]
Li, Chun-Sing [1 ]
Masse, Frederic [1 ]
Oballa, Renata [1 ]
Zhang, Lei [1 ]
机构
[1] Merck Frosst Ctr Therapeut Res, Pointe Claire, PQ H9R 4P8, Canada
关键词
SCD inhibitor; Stearoyl-CoA; Pyridazine; Thiadiazole; Bioavailable; STEAROYL-COA DESATURASE; COENZYME-A DESATURASE; PART I; DEFICIENCY; MICROSOMES; DISCOVERY; ENZYME; MICE;
D O I
10.1016/j.bmcl.2009.11.111
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of stearoyl-CoA desaturase 1 (SCD1) inhibitors were developed. Investigations of enzyme potency and metabolism led to the identification of the thiadiazole-pyridazine derivative MF-438 as a potent SCD1 inhibitor. MF-438 exhibits good pharmacokinetics and metabolic stability, thereby serving as a valuable tool for further understanding the role of SCD inhibition in biological and pharmacological models of diseases related to metabolic disorders. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:499 / 502
页数:4
相关论文
共 21 条
[1]   Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia [J].
Attie, AD ;
Krauss, RM ;
Gray-Keller, MP ;
Brownlie, A ;
Miyazaki, M ;
Kastelein, JJ ;
Lusis, AJ ;
Stalenhoef, AFH ;
Stoehr, JP ;
Hayden, MR ;
Ntambi, JM .
JOURNAL OF LIPID RESEARCH, 2002, 43 (11) :1899-1907
[2]   Comparative 1-substituted imidazole inhibition of cytochrome P450 isozyme-selective activities in human and mouse hepatic microsomes [J].
Franklin, Michael R. ;
Constance, Jonathan E. .
DRUG METABOLISM REVIEWS, 2007, 39 (2-3) :309-322
[3]  
Huang Z., UNPUB
[4]   Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans [J].
Hulver, MW ;
Berggren, JR ;
Carper, MJ ;
Miyazaki, M ;
Ntambi, JM ;
Hoffman, EP ;
Thyfault, JP ;
Stevens, R ;
Dohm, GL ;
Houmard, JA ;
Muoio, DM .
CELL METABOLISM, 2005, 2 (04) :251-261
[5]   Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1 [J].
Jiang, GQ ;
Li, ZH ;
Liu, F ;
Ellsworth, K ;
Dallas-Yang, Q ;
Wu, M ;
Ronan, J ;
Esau, C ;
Murphy, C ;
Szalkowski, D ;
Bergeron, R ;
Doebber, T ;
Zhang, BB .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (04) :1030-1038
[6]  
JOSHI VC, 1977, J LIPID RES, V18, P32
[7]   Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors [J].
Koltun, Dmitry O. ;
Zilbershtein, Timur M. ;
Migulin, Vasily A. ;
Vasilevich, Natalya I. ;
Parkhill, Eric Q. ;
Glushkov, Andrei I. ;
McGregor, Malcolm J. ;
Brunn, Sandra A. ;
Chu, Nancy ;
Hao, Jia ;
Mollova, Nevena ;
LeungF, Kwan ;
Chisholm, Jeffrey W. ;
Zablocki, Jeff .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) :4070-4074
[8]   Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors [J].
Koltun, Dmitry O. ;
Vasilevich, Natalya I. ;
Parkhill, Eric Q. ;
Glushkov, Andrei I. ;
Zilbershtein, Timur M. ;
Mayboroda, Elena I. ;
Boze, Melanie A. ;
Cole, Andrew G. ;
Henderson, Ian ;
Zautke, Nathan A. ;
Brunn, Sandra A. ;
Chu, Nancy ;
Hao, Jia ;
Mollova, Nevena ;
Leung, Kwan ;
Chisholm, Jeffrey W. ;
Zablocki, Jeff .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (11) :3050-3053
[9]   Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors [J].
Koltun, Dmitry O. ;
Parkhill, Eric Q. ;
Vasilevich, Natalya I. ;
Glushkov, Andrei I. ;
Zilbershtein, Timur M. ;
Ivanov, Alexei V. ;
Cole, Andrew G. ;
Henderson, Ian ;
Zautke, Nathan A. ;
Brunn, Sandra A. ;
Mollova, Nevena ;
Leung, Kwan ;
Chisholm, Jeffrey W. ;
Zablocki, Jeff .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (07) :2048-2052
[10]  
Li C. S., 2006, [No title captured], Patent No. [WO2006/130986, 2006130986]